Methods and compositions for minimizing accrual of inhalable insulin in the lungs

Details for Australian Patent Application No. 2006213084 (hide)

Owner MannKind Corporation

Inventors Boss, Anders; Gelber, Cohava

Agent Spruson & Ferguson

Pub. Number AU-A-2006213084

PCT Pub. Number WO2006/086107

Priority 60/643,054 10.01.05 US

Filing date 10 January 2006

Wipo publication date 17 August 2006

International Classifications

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 38/28 (2006.01) Medicinal preparations containing peptides - Insulins

A61K 47/22 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Heterocyclic compounds

C07D 241/08 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

Event Publications

2 August 2007 PCT application entered the National Phase

  PCT publication WO2006/086107 Priority application(s): WO2006/086107

17 December 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006213085-Use of inhibitors of soluble epoxide hydrolase to synergize activity of COX and 5-LOX inhibitors

2006213072-Inflation device for forming inflated containers